Patents by Inventor Qi-Long Ying

Qi-Long Ying has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF
    Publication number: 20210292712
    Abstract: The disclosure provides methods for the long-term expansion of granulocyte-macrophage progenitors, the granulocyte-macrophage progenitors generated therefrom, and uses of the granulocyte-macrophage progenitors thereof.
    Type: Application
    Filed: April 7, 2021
    Publication date: September 23, 2021
    Inventors: Qi-Long Ying, Shi Yue
  • Culture medium containing kinase inhibitors, and uses thereof
    Patent number: 9074180
    Abstract: Pluripotent cells are maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and, optionally, an antagonist of an FGF receptor. Pluripotent cells are also maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor and an antagonist of an FGF receptor.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: July 7, 2015
    Assignee: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
    Inventors: Austin Gerard Smith, Qi-Long Ying
  • Pluripotent Cells From Rat and Other Species
    Publication number: 20130333058
    Abstract: Pluripotent cells are derived and maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and an antagonist of an FGF receptor.
    Type: Application
    Filed: April 5, 2013
    Publication date: December 12, 2013
    Applicant: The University Court of The University of Edinburgh
    Inventors: Qi-Long Ying, Austin Gerard Smith
  • Pluripotent cells from rat and other species
    Patent number: 8431395
    Abstract: Pluripotent cells are derived and maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and an antagonist of an FGF receptor.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: April 30, 2013
    Assignee: The University Court of the University of Edinburgh
    Inventors: Qi-Long Ying, Austin Gerard Smith
  • CULTURE MEDIUM CONTAINING KINASE INHIBITORS, AND USES THEREOF
    Publication number: 20100041137
    Abstract: Pluripotent cells are maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and, optionally, an antagonist of an FGF receptor. Pluripotent cells are also maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor and an antagonist of an FGF receptor.
    Type: Application
    Filed: October 20, 2009
    Publication date: February 18, 2010
    Applicant: The University Court of the University of Edingburgh
    Inventors: Austin Gerard Smith, Qi-Long Ying
  • Culture Medium Containing Kinase Inhibitor, and Use Thereof
    Publication number: 20090130759
    Abstract: Pluripotent cells are maintained in a self-renewing state in serum-free culture medium comprising a gp130 agonist (LIF) and a GSK3 inhibitor.
    Type: Application
    Filed: March 22, 2006
    Publication date: May 21, 2009
    Applicant: The University Court of the University of Edinburgh
    Inventors: Austin Gerard Smith, Qi-Long Ying
  • Control of ES Cell Self Renewal and Lineage Specification, and Medium Therefor
    Publication number: 20080145936
    Abstract: Self renewal of pluripotent cells in culture is promoted using a combination of an activator of a signalling pathway downstream of a receptor of the TGF-? superfamily and an activator of a gp130 downstream signalling pathway.
    Type: Application
    Filed: January 7, 2008
    Publication date: June 19, 2008
    Applicant: University of Edinburgh
    Inventors: Austin Gerard Smith, Qi-Long Ying
  • PLURIPOTENT CELLS FROM RAT AND OTHER SPECIES
    Publication number: 20080066197
    Abstract: Pluripotent cells are derived and maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and an antagonist of an FGF receptor.
    Type: Application
    Filed: August 1, 2007
    Publication date: March 13, 2008
    Applicant: The University Court of The University of Edinburgh
    Inventors: Qi-Long Ying, Austin Smith
  • CULTURE MEDIUM CONTAINING KINASE INHIBITORS, AND USES THEREOF
    Publication number: 20080014638
    Abstract: Pluripotent cells are maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor, a GSK3 inhibitor and, optionally, an antagonist of an FGF receptor. Pluripotent cells are also maintained in a self-renewing state in serum-free culture medium comprising a MEK inhibitor and an antagonist of an FGF receptor.
    Type: Application
    Filed: March 30, 2007
    Publication date: January 17, 2008
    Applicant: The University Court of the University of Edinburgh
    Inventors: Austin Smith, Qi-Long Ying
  • Control of es cell self renewal and lineage specification, and medium therefor
    Publication number: 20070178439
    Abstract: Self renewal of pluripotent cells in culture is promoted using a combination of an Id gene product and an activator of a gp130 downstream signalling pathway.
    Type: Application
    Filed: October 15, 2004
    Publication date: August 2, 2007
    Inventors: Austin Smith, Qi-Long Ying, Jennifer Nichols
  • Control of es cell self renewal and lineage specification, and medium therefor
    Publication number: 20050221478
    Abstract: Self renewal of pluripotent cells in culture is promoted using a combination of an activator of a signalling pathway downstream of a receptor of the TGF-? superfamily and an activator of a gp130 downstream signalling pathway.
    Type: Application
    Filed: May 8, 2003
    Publication date: October 6, 2005
    Inventors: Austin Smith, Qi-Long Ying